Work

Baseline albumin (b-alb) as a potential predictive biomarker for the efficacy of bevacizumab (B) therapy (tx) in patients (pts) with advanced pancreas cancer (APCA): A comparative analysis.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.4039

Authors: Ludmila Katherine Martin, Susan Michelle Geyer, Anissa Bingman, Mark M. Zalupski, Tanios S. Bekaii-Saab

Institutions: The Ohio State University Wexner Medical Center, The Ohio State University, U-M Rogel Cancer Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2969884919

Cites:

Cited by: 1

Related to: 10